303 related articles for article (PubMed ID: 27164080)
1. Interaction between Mesenchymal Stem Cells and B-Cells.
Fan L; Hu C; Chen J; Cen P; Wang J; Li L
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27164080
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
3. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1/early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus.
Feng X; Che N; Liu Y; Chen H; Wang D; Li X; Chen W; Ma X; Hua B; Gao X; Tsao BP; Sun L
Arthritis Rheumatol; 2014 Dec; 66(12):3413-23. PubMed ID: 25219468
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of B-cell proliferation and antibody production by mesenchymal stromal cells is mediated by T cells.
Rosado MM; Bernardo ME; Scarsella M; Conforti A; Giorda E; Biagini S; Cascioli S; Rossi F; Guzzo I; Vivarelli M; Dello Strologo L; Emma F; Locatelli F; Carsetti R
Stem Cells Dev; 2015 Jan; 24(1):93-103. PubMed ID: 25036865
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of the immunosuppressive properties of mesenchymal stromal cells.
de Castro LL; Lopes-Pacheco M; Weiss DJ; Cruz FF; Rocco PRM
J Mol Med (Berl); 2019 May; 97(5):605-618. PubMed ID: 30903229
[TBL] [Abstract][Full Text] [Related]
6. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
7. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation by mesenchymal stem cells and clinical experience.
Le Blanc K; Ringdén O
J Intern Med; 2007 Nov; 262(5):509-25. PubMed ID: 17949362
[TBL] [Abstract][Full Text] [Related]
9. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.
Traggiai E; Volpi S; Schena F; Gattorno M; Ferlito F; Moretta L; Martini A
Stem Cells; 2008 Feb; 26(2):562-9. PubMed ID: 18024418
[TBL] [Abstract][Full Text] [Related]
11. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
[TBL] [Abstract][Full Text] [Related]
12. B Lymphocytes Are the Target of Mesenchymal Stem Cells Immunoregulatory Effect in a Murine Graft-versus-Host Disease Model.
Lu D; Ma T; Zhou X; Jiang Y; Han Y; Li H
Cell Transplant; 2019; 28(9-10):1279-1288. PubMed ID: 31257911
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy and acute graft-versus-host disease: a review.
Amorin B; Alegretti AP; Valim V; Pezzi A; Laureano AM; da Silva MA; Wieck A; Silla L
Hum Cell; 2014 Oct; 27(4):137-50. PubMed ID: 24903975
[TBL] [Abstract][Full Text] [Related]
15. Highlighting the interaction between immunomodulatory properties of mesenchymal stem cells and signaling pathways contribute to Graft Versus Host Disease management.
Mirfakhraie R; Ardakani MT; Hajifathali A; Karami S; Moshari MR; Hassani M; Firouz SM; Roshandel E
Transpl Immunol; 2022 Apr; 71():101524. PubMed ID: 34990789
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease.
Christensen ME; Turner BE; Sinfield LJ; Kollar K; Cullup H; Waterhouse NJ; Hart DN; Atkinson K; Rice AM
Haematologica; 2010 Dec; 95(12):2102-10. PubMed ID: 20801899
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
Front Immunol; 2021; 12():714832. PubMed ID: 34603289
[TBL] [Abstract][Full Text] [Related]
18. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications.
Castro-Manrreza ME; Montesinos JJ
J Immunol Res; 2015; 2015():394917. PubMed ID: 25961059
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulatory effects of dental mesenchymal stem cells on T and B lymphocyte responses in primary Sjögren's syndrome.
Genç D; Günaydın B; Sezgin S; Aladağ A; Tarhan EF
Immunotherapy; 2022 Mar; 14(4):225-247. PubMed ID: 35012368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
